Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Replacement Heart-Conduit Valve Implanted Without Surgery

By HospiMedica International staff writers
Posted on 08 Feb 2010
An innovative transcatheter pulmonary valve (TPV) offers a nonsurgical valve replacement option for patients with congenital heart disease (CHD). More...


The Melody TPV is delivered through a catheter requiring only a small incision, and should benefit children and adults born with a malformation of the pulmonary valve. Deep coaptation of the Melody TPV leaflets provides valve competency across a range of diameters and geometries, and natural venous valve leaflets open and close under minimal pressure for optimal hemodynamics. Sutures at every node of the TPV are designed to enhance valve integrity. The Melody TPV is delivered via the Ensemble transcatheter delivery system, using fluoroscopic guidance. The 22 French delivery catheter offers a low crossing profile, and a balloon-in-balloon deployment enables minor adjustments to facilitate accurate placement. A unique coverage sheath protects the valve during delivery up to the point of deployment.

Similar to other conduits, the Melody TPV does not cure the heart condition and over time may wear and require replacement. But since it is implanted without open heart surgery, it can prop open the poorly functioning conduit and can keep blood flowing in the proper direction, which will allow a patient's conduit to function longer than usual, delaying the need for more invasive open-heart surgery. The Melody TPV and the Ensemble delivery system are products of Medtronic (Minneapolis, MN, USA), and have received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).

"The Melody Transcatheter Pulmonary Valve is a significant technological breakthrough and offers a reprieve for many patients with congenital heart disease – many of whom are young and will require several heart surgeries over their lifetime,” said pediatric cardiologist William Hellenbrand, M.D., of Columbia University Medical Center (New York, NY, USA). "The Melody valve gives patients with congenital heart disease a new, nonsurgical approach to managing their disease.”

Conduits are surgically implanted valves used to treat patients with congenital heart defects that have narrowed, leaky, or missing pulmonary valves that impede the proper flow of blood from the heart's right ventricle to the pulmonary artery, which then sends the blood on to the lungs for oxygenation.

Related Links:

Medtronic



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.